(Q49025983)

17 February 2018

title

Neurochemical neutralization of amphetamine-type stimulants in rat brain by the indatraline analog (-)-HY038. (English)

1 reference

17 February 2018

author name string

Partilla JS

1

1 reference

17 February 2018

Dersch CM

2

1 reference

17 February 2018

Yu H

3

1 reference

17 February 2018

Rice KC

4

1 reference

17 February 2018

Rothman RB

5

1 reference

17 February 2018

publication date

1 December 2000

1 reference

17 February 2018

published in

Brain Research Bulletin

1 reference

17 February 2018

volume

53

1 reference

17 February 2018

issue

6

1 reference

17 February 2018

page(s)

821-826

1 reference

17 February 2018

3-Phenyl-1-indanamines. Potential antidepressant activity and potent inhibition of dopamine, norepinephrine, and serotonin uptake

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Memory impairment in abstinent MDMA ("Ecstasy") users.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate, a long-acting ester derivative of GBR 12909.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Design, synthesis, and monoamine transporter binding site affinities of methoxy derivatives of indatraline

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Studies of selected phenyltropanes at monoamine transporters

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Neurotoxic amphetamine analogues: effects in monkeys and implications for humans

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

From synapse to vesicle: the reuptake and storage of biogenic amine neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C] WIN35,428 PET scans.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Neurobiology of addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

Binding domains for blockers and substrates on the dopamine transporter in rat striatal membranes studied by protection against N-ethylmaleimide-induced reduction of [3H]WIN 35,428 binding.

1 reference

https://api.crossref.org/works/10.1016%2FS0361-9230%2800%2900419-6

7 January 2021

10.1016/S0361-9230(00)00419-6

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018